轻型急性缺血性卒中静脉溶栓的随机对照试验荟萃分析
该荟萃分析仅纳入随机对照试验,比较静脉溶栓与非溶栓标准治疗在轻型急性缺血性卒中患者中的效果。共纳入9篇报告含13项随机对照试验,结果显示静脉溶栓与良好功能恢复无显著关联,且与较低功能独立几率、较高症状性颅内出血和90天死亡率相关。结论提示静脉溶栓对轻型非致残性卒中未额外获益。
要点
- 静脉溶栓与良好功能恢复无显著关联(OR 0.85,95%CI 0.70-1.03)。
- 静脉溶栓与较低功能独立几率及较高症状性颅内出血和90天死亡率相关。
- 结论支持静脉溶栓对轻型非致残性卒中不优于非溶栓标准治疗。
核心结论
- 该荟萃分析提示静脉溶栓对轻型非致残性卒中未较非溶栓标准治疗带来额外获益。
研究设计与样本
- 仅纳入随机对照试验,共识别9篇报告涵盖13项随机对照试验,采用多种分析方法处理异质性。
主要发现
- 静脉溶栓与良好功能恢复无显著关联(OR 0.85,95%CI 0.70-1.03)。
- 静脉溶栓与较低功能独立几率及较高症状性颅内出血和90天死亡率相关。
临床怎么用
- 针对轻型非致残性急性缺血性卒中,静脉溶栓不应常规视为优于非溶栓标准治疗。
局限性
- 纳入研究数量少,无法正式评估发表偏倚。
- 排除观察性及准实验研究,可能遗漏真实世界证据。
- 轻型卒中定义存在变异。
- 改良Rankin量表等传统结局指标对疲劳、重返工作等非运动功能缺陷不敏感。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drawing exclusively from randomized controlled trials (RCTs), the meta-analysis by Doheim et al. evaluates the comparative effectiveness of intravenous thrombolysis (IVT) vs nonthrombolytic standard of care (NT-SC) in patients with minor acute ischemic stroke (AIS). The authors identified 9 reports encompassing 13 RCTs. Multiple analytical approaches (Q and I2 measures, leave-out-one analyses, sensitivity analyses) were performed to address study heterogeneity. Findings show that, compared with NT-SC, IVT was not significantly associated with excellent functional recovery poststroke (odds ratio 0.85, 95% CI 0.70-1.03). IVT was associated with lower odds of achieving functional independence and higher odds of symptomatic intracranial hemorrhage and mortality at 90 days. A major strength is the study's exclusive inclusion of RCTs, which minimizes methodological heterogeneity and enhances internal validity. Limitations include (1) small number of included studies precluding formal assessment of publication bias; (2) exclusion of observational or quasiexperimental studies, potentially overlooking valuable real-world evidence; (3) variability in the definition of minor AIS; and (4) insensitivity of conventional outcome measures such as the modified Rankin Scale to capture nonmotor functional deficits such as fatigue and return-to-work capability, which are highly relevant to patients with minor stroke but remain underrepresented in traditional assessments. In conclusion, this meta-analysis suggests that IVT does not confer additional benefit over NT-SC for minor nondisabling stroke. Future studies would benefit from incorporating broader, patient-centered functional outcomes to better capture the subtleties of disability in this patient population.
引用
- Teo KSH, Ong JM, Yeo JYP, et al. Neurology® Journal Club: Meta-Analysis of Randomized Controlled Trials on IV Thrombolysis in Patients With Minor Acute Ischemic Stroke. Neurology. 2026. PMID: 42335433. doi:10.1212/WNL.0000000000218252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。